Navigation Links
Antibody Technologies and Attrition Rates -- an industry analysis 2013
Date:3/27/2013

NEW YORK, March 27, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Antibody Technologies and Attrition Rates – an industry analysis 2013

http://www.reportlinker.com/p01154426/Antibody-Technologies-and-Attrition-Rates-–-an-industry-analysis-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

Product Description

The report "Antibody Technologies and Attrition Rates – an industry analysis 2013" is based on the identification of the antibody generation technologies of 504 naked antibodies in clinical or market stages. Information was retrieved from scientific and corporate publications as well as from patent and legal literature. The report provides descriptive statistics of the 504 naked antibodies and their status during the study period of January 1, 2013 to February 28, 2013. The antibodies are categorized as active during the study period or discontinued during or before the study period. Attrition rates were calculated across a number of variables.

Descriptive statistics of the 504 naked antibodies include the following variables:

  • Unique antibody identifiers (drug codes; generic name; brand name)
  • Antibody format (full length, Fab, scFv, VH/VL, nanobody, bispecific, cocktail/polyclonal)
  • In vitro antibody generation technologies (display technologies from CAT, Dyax, Morphosys, BioInvent, Domantis, G
    '/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. iBio Adds New Therapeutic Antibody to Its Pipeline
2. Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40
3. Monoclonal Antibody Partnering Terms & Agreements Discussed in New Report Now Available at MarketPublishers.com
4. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
5. NKT Therapeutics Presents Data on Potential Antibody Treatment for Sickle Cell Disease
6. Ebola antibody treatment, produced in plants, protects monkeys from lethal disease
7. Preclinical data shows 100 percent prevention and treatment of influenza with engineered human antibody
8. Oncobiologics, Inc. Announces a Collaboration Agreement with XOMA Corporation to Utilize XOMAs Fully Human Antibody Libraries for Their Discovery Platform
9. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
10. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
11. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 ... cell therapy in the US aimed at improving the ... their newest clinical study for Parkinson’s disease. StemGenex ... of stem cell therapy are paramount when providing care ... clinical study makes stem cell therapy accessible to the ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... , July 23, 2014 regulated information ... research and development pipeline with positive topline results ... brivaracetam . This study was designed to evaluate the ... and 200 mg/day, without titration) compared to placebo, ... with partial-onset seizures, not fully controlled despite treatment ...
(Date:7/23/2014)... VEGAS , July 23, 2014  GrowBLOX Sciences, Inc. ... today that it is filing for two medical marijuana dispensary ... locations are in addition to the Clark County, ... a special use permit, as previously announced.  GrowBLOX ... to be submitting two new applications for dispensaries in the ...
Breaking Biology Technology:StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3
... 11 Signalife,Inc. (Amex: SGN ) announced ... its previously-announced merger or similar business combination with,Heart ... has been,appointed to proceed with due diligence and ... presently contemplated, a new parent,company will be established ...
... Ltd. launches a multicenter study using the CiTop™ technology in ... device company, has announced today successful experiences using CiTop™ ExPander™ ... , ... Rehovot , Israel (PRWEB) ...
... (T-ALL) , The white blood cells in our ... However, in leukemia, the formation of white blood cells ... blood cells multiply out of control without fully maturing. ... making patients more susceptible to infections. T-ALL, a particular ...
Cached Biology Technology:Signalife Board Approves Merger 2Signalife Board Approves Merger 3Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire 2Not the protein, but its location in the cell, determines the onset of leukemia 2
(Date:7/23/2014)... and forming knots. Scientists study these knots to understand ... useful for gene sequencing techniques). Cristian Micheletti, professor at ... and his team have been carrying out research in ... their latest paper, just published in the journal ... first author and PhD student at SISSA, and colleagues ...
(Date:7/23/2014)... release is available in German . ... sensory modalities for orientation, some of which might be ... take the polarization pattern produced by sunlight in the ... the Max Planck Institute for Ornithology in Seewiesen, Germany, ... Israel that a night active mammal, the greater mouse-eared ...
(Date:7/23/2014)... for Alzheimer,s disease, the devastating neurological disease affecting ... now reporting new progress on a set of ... promise as a potential oral therapy for Alzheimer,s. ... Medicinal Chemistry . , Carlo Ballatore, Kurt R. ... brain, the protein known as tau binds to ...
Breaking Biology News(10 mins):Bats use the evening sky's polarization pattern for orientation 2
... flu spread from Mexico to Texas and then fanned out ... behavior. Families kept children home from school, postponed trips to ... so doing, the American population may have inadvertently altered the ... the spread of emerging infectious diseases, and how the spread ...
... 4 April 2009 | An international symposium ... the use of nuclear technologies to enhance animal nutrition and ... can be transmitted to humans, such as swine and avian ... over 100 countries will present up-to-date findings for solving or ...
... a relatively widespread phenomenon, the experts have still not been ... of workplace abuse or bullying. Basing their work on previous ... Madrid and Jos Lus Graa, of the Faculty of Psychology ... as a "process of systematic and repeated aggression by a ...
Cached Biology News:Scientists examine perceptions of risk and the spread of disease 2FAO/IAEA Symposium to address animal production and health 2Bullies have harassed 14 percent of workers over past 6 months 2
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... 1 outflow Single-cell and patch delivery ... solution change Very small dead volume , ... 360, 250 and 100 micron delivery tips ... micromanipulator Available in 4, 8, and 16 ...
Biology Products: